Read the ruling here.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
BROOKLYN — A federal court in New York tossed the third-amended false advertising complaint brought over at-home ovulation test kits sold at retailers under the Clearblue and First Response brands. The suing customers say the products cannot predict when someone is ovulating with 99% accuracy; the court says that reasonable consumers will read the side and back labeling, which state the products test not for ovulation but for a rise in luteinizing hormone levels, which typically suggest ovulation will occur in the next day and a half.